quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:44:13·1735d
INSIDERFiling
Alexion Pharmaceuticals, Inc. logo

SEC Form 4: Brennan David R returned 20,873 units of Common Stock to the company, closing all direct ownership in the company

ALXN· Alexion Pharmaceuticals, Inc.
Health Care
Original source

Companies

  • ALXN
    Alexion Pharmaceuticals, Inc.
    Health Care

Related

  • PR226d
    Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
  • SEC1726d
    SEC Form 15-12G filed by Alexion Pharmaceuticals, Inc.
  • SEC1733d
    SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
  • SEC1733d
    SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
  • SEC1733d
    SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
  • SEC1733d
    SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
  • SEC1733d
    SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
  • SEC1733d
    SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022